Zomedica partners with VMG to expand access to veterinary technologies across 2,000 US clinics

• Zomedica struck a strategic partnership with Veterinary Management Groups, becoming a preferred provider to a network of more than 2,000 U.S. members.
• Deal runs from Sept. 1, 2026 to Aug. 31, 2028, expanding distribution of diagnostic, therapy, hemostasis, and remote monitoring products.
• TRUFORMA in-clinic endocrine testing, PulseVet shock wave therapy, Assisi tPEMF devices highlighted as key technologies under the program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609220600ACCESSWRNAPR_____1225087) on September 22, 2026, and is solely responsible for the information contained therein.